Here are some clinical trials for Parkinson’s disease in Palm Beach, Florida:
1. **Parkinson’s Disease Clinical Trial**: This is a phase III clinical trial studying the safety and efficacy of a new medication for the treatment of Parkinson’s disease. The trial is being conducted at the University of Miami’s Miller School of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing motor fluctuations.
Contact: (305) 243-5555
2. **Deep Brain Stimulation for Parkinson’s Disease**: This is a phase II clinical trial studying the safety and efficacy of deep brain stimulation for the treatment of Parkinson’s disease. The trial is being conducted at the Cleveland Clinic Florida in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing motor symptoms.
Contact: (954) 659-5555
3. **Parkinson’s Disease and Depression**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of depression in patients with Parkinson’s disease. The trial is being conducted at the University of Florida’s College of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing depression.
Contact: (352) 392-5555
4. **Parkinson’s Disease and Cognitive Impairment**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of cognitive impairment in patients with Parkinson’s disease. The trial is being conducted at the University of Miami’s Miller School of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing cognitive impairment.
Contact: (305) 243-5555
5. **Parkinson’s Disease and Gastrointestinal Symptoms**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of gastrointestinal symptoms in patients with Parkinson’s disease. The trial is being conducted at the Cleveland Clinic Florida in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing gastrointestinal symptoms.
Contact: (954) 659-5555
6. **Parkinson’s Disease and Sleep Disturbances**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of sleep disturbances in patients with Parkinson’s disease. The trial is being conducted at the University of Florida’s College of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing sleep disturbances.
Contact: (352) 392-5555
7. **Parkinson’s Disease and Exercise**: This is a phase II clinical trial studying the safety and efficacy of exercise therapy for the treatment of Parkinson’s disease. The trial is being conducted at the University of Miami’s Miller School of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing motor symptoms.
Contact: (305) 243-5555
8. **Parkinson’s Disease and Nutrition**: This is a phase II clinical trial studying the safety and efficacy of a new nutrition therapy for the treatment of Parkinson’s disease. The trial is being conducted at the Cleveland Clinic Florida in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing nutritional deficiencies.
Contact: (954) 659-5555
Please note that clinical trials are subject to change, and it’s essential to verify the eligibility criteria and contact information before participating. You can also search for more clinical trials on websites like ClinicalTrials.gov or the National Parkinson Foundation’s website.Here are some clinical trials for Parkinson’s disease in Palm Beach, Florida:
1. **Parkinson’s Disease Clinical Trial**: This is a phase III clinical trial studying the safety and efficacy of a new medication for the treatment of Parkinson’s disease. The trial is being conducted at the University of Miami’s Miller School of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing motor fluctuations.
Contact: (305) 243-5555
2. **Deep Brain Stimulation for Parkinson’s Disease**: This is a phase II clinical trial studying the safety and efficacy of deep brain stimulation for the treatment of Parkinson’s disease. The trial is being conducted at the Cleveland Clinic Florida in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing motor symptoms.
Contact: (954) 659-5555
3. **Parkinson’s Disease and Depression**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of depression in patients with Parkinson’s disease. The trial is being conducted at the University of Florida’s College of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing depression.
Contact: (352) 392-5555
4. **Parkinson’s Disease and Cognitive Impairment**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of cognitive impairment in patients with Parkinson’s disease. The trial is being conducted at the University of Miami’s Miller School of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing cognitive impairment.
Contact: (305) 243-5555
5. **Parkinson’s Disease and Gastrointestinal Symptoms**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of gastrointestinal symptoms in patients with Parkinson’s disease. The trial is being conducted at the Cleveland Clinic Florida in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing gastrointestinal symptoms.
Contact: (954) 659-5555
6. **Parkinson’s Disease and Sleep Disturbances**: This is a phase II clinical trial studying the safety and efficacy of a new medication for the treatment of sleep disturbances in patients with Parkinson’s disease. The trial is being conducted at the University of Florida’s College of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing sleep disturbances.
Contact: (352) 392-5555
7. **Parkinson’s Disease and Exercise**: This is a phase II clinical trial studying the safety and efficacy of exercise therapy for the treatment of Parkinson’s disease. The trial is being conducted at the University of Miami’s Miller School of Medicine in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing motor symptoms.
Contact: (305) 243-5555
8. **Parkinson’s Disease and Nutrition**: This is a phase II clinical trial studying the safety and efficacy of a new nutrition therapy for the treatment of Parkinson’s disease. The trial is being conducted at the Cleveland Clinic Florida in Palm Beach.
Eligibility: Patients with Parkinson’s disease who are experiencing nutritional deficiencies.
Contact: (954) 659-5555
Please note that clinical trials are subject to change, and it’s essential to verify the eligibility criteria and contact information before participating. You can also search for more clinical trials on websites like ClinicalTrials.gov or the National Parkinson Foundation’s website.